Entrada Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $214k | 14k | 15.09 |
| 2023-09-30 | $230k | 15k | 15.80 |
| 2023-06-30 | $252k | 17k | 15.14 |
| 2023-03-31 | $124k | 8.5k | 14.52 |
| 2022-12-31 | $103k | 7.6k | 13.57 |
| 2022-03-31 | $46k | 4.9k | 9.32 |
| 2021-12-31 | $60k | 3.5k | 17.17 |